Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Women with PCOS, especially if they are obese, are more likely to have an underactive thyroid than women without PCOS.

PCOS women with COVID-19 have higher cardiometabolic risks.

Higher androgen levels and site-specific AR expression cause sex-related skeletal differences, and certain steroids can boost AR expression and androgen effects in bone cells.

Early-onset male hair loss is linked to metabolic syndrome, suggesting a need for heart health monitoring and lifestyle changes.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

IGF-1R may play a role in female hair loss and could be a treatment target.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Trichoscopy can diagnose female hair loss with high accuracy by looking for specific patterns in hair and scalp appearance.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

A new method effectively predicts estrogen-related health effects for early screening.

Acne in adult women is often linked to polycystic ovary syndrome, especially in those who are younger, have premenstrual acne flare-ups, and irregular periods.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

The Greek DCQ is a reliable and valid tool for assessing dysmorphic concern.

Free testosterone is the most common hormone marker in PCOS, and age affects DHEAS levels.

Higher insulin levels are linked to larger ovaries in women with idiopathic hirsutism.

Women with high androgen levels may have more severe COVID-19 symptoms.

People with early hair loss may have higher insulin levels and a greater chance of developing metabolic syndrome.

Most women lack knowledge about androgens and their excess symptoms.

Hair diameter difference, brown skin discoloration around hair follicles, and missing hair in certain areas are key signs of androgenetic alopecia (commonly known as hair loss) when viewed under a dermoscope.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Women with PCOS have different hormone levels compared to those without PCOS.

Androgenetic alopecia in males is linked to significant psychological distress, highlighting the need for both mental and dermatological care.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

A rare ovarian tumor caused high testosterone in a postmenopausal woman, resolved by surgery.

A testosterone-induced hair loss model in mice was successfully created for future research and treatment testing.

Androgenetic alopecia significantly affects mental health and quality of life, highlighting the need for psychiatric evaluations.